Luc-Alain Savoy, PhD
Chairman
Dr. Savoy is co-founder and chairman of BioXpress Therapeutics SA. Previously, he co-founded in 1991 M-Scan SA, a contract research organization specializing in high level of bioproducts characterization, prior to selling it to SGS. Luc-Alain pioneered physico chemical characterization using high end mass spectrometry methodologies, which have become worldwide standards for the analysis of complex biologic products. He is currently Global Head of Biologics, at SGS Life Sciences. Dr. Savoy has worked on more than 10 biosimilarity packages for clients.
Gerrit Hagens, PhD, MBA
Director
Dr. Hagens is director at BioXpress and Professor at the University of Applied Sciences HES-SO, Sion, Switzerland. Gerrit Hagens gained a strong manufacturing process development experience during the last 20 years in the industry. Before joining BioXpress where he heads project management since 2010, he was member of Serono’s core team managing the Neurology Business Unit bringing Rebif for treating multiple sclerosis to a blockbuster status. He then took over executive roles at ExcellGene and RiboVax as COO and President and helped developing manufacturing processes for biologics. Gerrit is also co-founder of NatiMab, a company specialized in the development of antibody-based therapies and diagnostics.
Based in Geneva, Switzerland, the Company was founded by industry leaders biologic drug development, including cell-line development and analytical characterization and has built a team of experts in the production of biopharmaceuticals and biosimilars.